GERM CELL TUMOUR Clinical Trials

7 clinical trials for GERM CELL TUMOUR across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A PHASE II TRIAL EVALUATING CHEMOTHERAPY FOLLOWED BY RESPONSE-BASED REDUCED RADIATION THERAPY FOR PATIENTS WITH CENTRAL NERVOUS SYSTEM GERMINOMAS — RECRUITING · PHASE2
• A PHASE 2 TRIAL OF CHEMOTHERAPY FOLLOWED BY RESPONSE-BASED WHOLE VENTRICULAR & SPINAL CANAL IRRADIATION (WVSCI) FOR PATIENTS WITH LOCALIZED NONGERMINOMATOUS CENTRAL NERVOUS SYSTEM GERM CELL TUMOR — RECRUITING · PHASE2
• PHASE 3 ACCELERATED BEP TRIAL: A RANDOMISED PHASE 3 TRIAL OF ACCELERATED VERSUS STANDARD BEP CHEMOTHERAPY FOR PATIENTS WITH INTERMEDIATE AND POOR-RISK METASTATIC GERM CELL TUMOURS — RECRUITING · PHASE3
• A PHASE 3 STUDY OF ACTIVE SURVEILLANCE FOR LOW RISK AND A RANDOMIZED TRIAL OF CARBOPLATIN VS. CISPLATIN FOR STANDARD RISK PEDIATRIC AND ADULT PATIENTS WITH GERM CELL TUMOURS — RECRUITING · PHASE3
• A PILOT FEASIBILITY STUDY OF A STEROID-SPARING ANTI-NAUSEA AND VOMITING REGIMEN WITH NETUPITANT/PALONOSETRON FOR PATIENTS WITH GERM CELL TUMOURS RECEIVING MULTI-DAY CISPLATIN-BASED CHEMOTHERAPY AT THE OTTAWA HOSPITAL — NOT_YET_RECRUITING
• A Novel Single Arm Phase II Study for Relapsed Germ Cell Tumours With Poor Prognosis — COMPLETED · PHASE2
• A RANDOMIZED PHASE III TRIAL COMPARING CONVENTIONAL-DOSE CHEMOTHERAPY USING PACLITAXEL, IFOSFAMIDE, AND CISPLATIN (TIP) WITH HIGH-DOSE CHEMOTHERAPY USING MOBILIZING PACLITAXEL PLUS IFOSFAMIDE FOLLOWED BY HIGH-DOSE CARBOPLATIN AND ETOPOSIDE (TI-CE) AS FIRST SALVAGE TREATMENT IN RELAPSED OR REFRACTORY GERM CELL TUMORS — NOT_YET_RECRUITING · PHASE3

Refine this search